These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. An audience with... Jan M. Lundberg. Lundberg JM Nat Rev Drug Discov; 2005 Jun; 4(6):452. PubMed ID: 15959949 [No Abstract] [Full Text] [Related]
24. Pharmaceutical trials in the research program. Steven ID Aust Fam Physician; 1996 Sep; 25(9 Suppl 2):S51-2. PubMed ID: 8854406 [No Abstract] [Full Text] [Related]
25. Industry shifts focus to immunology and cancer. Ledford H Nature; 2008 Nov; 456(7218):6. PubMed ID: 19004069 [No Abstract] [Full Text] [Related]
27. Clinical setbacks for toll-like receptor 9 agonists in cancer. Schmidt C Nat Biotechnol; 2007 Aug; 25(8):825-6. PubMed ID: 17687345 [No Abstract] [Full Text] [Related]
28. Overcoming the challenges in the pharma/biotech industry. Graul AI; Prous JR Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900 [TBL] [Abstract][Full Text] [Related]
29. Stroke treatment--light at the end of the tunnel? Garber K Nat Biotechnol; 2007 Aug; 25(8):838-40. PubMed ID: 17687351 [No Abstract] [Full Text] [Related]
31. Pharmaceutical futures: made in China? Cyranoski D Nature; 2008 Oct; 455(7217):1168-70. PubMed ID: 18971994 [No Abstract] [Full Text] [Related]
32. John Dillinger and clinical trials. Casey R Can J Urol; 2007 Oct; 14(5):3715. PubMed ID: 17949530 [No Abstract] [Full Text] [Related]
33. Erosion of the principal investigator role in a climate of industry dominance. Rowinsky EK Eur J Cancer; 2005 Oct; 41(15):2206-9. PubMed ID: 16162405 [TBL] [Abstract][Full Text] [Related]
34. Viewpoint: Sir Richard Sykes, DSc, FRS, FMedSci. Interview by Ingrid Torjesen, BSc. Sykes R Circulation; 2006 Jun; 113(22):f85-6. PubMed ID: 16754809 [No Abstract] [Full Text] [Related]
35. Leaders worry that U.S. is losing edge on cancer clinical trials. Twombly R J Natl Cancer Inst; 2008 Sep; 100(17):1196-9. PubMed ID: 18728275 [No Abstract] [Full Text] [Related]
37. Design, conduct, and analysis of clinical trials in disease due to methicillin-resistant Staphylococcus aureus. Powers JH; Fleming TR Clin Pharmacol Ther; 2009 Sep; 86(3):244-7. PubMed ID: 19707216 [TBL] [Abstract][Full Text] [Related]
38. Recurrent issues in the review of medical research on human subjects. Moore DL Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123 [No Abstract] [Full Text] [Related]
39. Back to basics: from industry to academia. Powell K Nature; 2004 Aug; 430(7000):706-7. PubMed ID: 15295606 [No Abstract] [Full Text] [Related]
40. The decline of pharmaceutical psychiatry and the increasing role of psychological medicine. Fava GA Psychother Psychosom; 2009; 78(4):220-7. PubMed ID: 19401622 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]